Tim-3 identified as promising therapeutic target for Alzheimer’s disease
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer’s disease (AD), but its
Read moreTim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer’s disease (AD), but its
Read moreRyan Coburn and Clark Wright explore the common problems encountered with difficult-to-handle materials and explains how selecting the right feeder
Read moreLeuze‘s 33C and 35C sensor series with stainless-steel housings is sutiable for hygiene-sensitive production and demanding industrial cleaning processes. With
Read morePublished: 09 April, 2025 Fugro and Spoor, a software company that helps renewable energy projects reduce their environmental impact, have
Read morePublished: 09 April, 2025 With just a few weeks to go before All-Energy opens at Glasgow’s SEC, the UK’s largest
Read moreNew research presented at the 2025 European Congress of Psychiatry reveals that the use of cannabidiol (CBD) cannabis extract can
Read moreA new study by the University of Turku and Turku University Hospital, Finland, found that a significant proportion of Parkinson’s
Read moreNew research from The University of Manchester may reshape our understanding of what happens to the immune system when we
Read moreEmerson announces the Flexim FLUXUS/PIOX 731 series, a new range of non-intrusive, clamp-on, ultrasonic flow meters designed to offer greater flexibility,
Read moreA new pilot study from UBC Okanagan and Thompson Rivers University examined how medically supervised cannabis use in a residential
Read more